We're assembling a online advisory panel to explore the current and future state of Myeloma cancer treatments. Specifically, we'll discuss the impact of generic availability of foundational therapies, new discoveries, and the impact on the best treatment options for patients.
A professional facilitator will be leading an open & honest discussion. In this collaborative engagement, you will be one of 20 equal-caliber peers in your field. You will have the unique opportunity to gain recognition for advancing the industry and demonstrate your thought-leadership -- in addition to earning merit-based compensation.
1. Exploring a variety of themes
2. Map the competitive landscape (i.e. emerging trends, disruptive tech, etc.)
3. React to the latest media/reports in this space
4. Enjoy the option of one-to-one engagement with other board members
Participation is 100% online and at your own convenience. By applying here, you are committing to participate once per week or as inspired, at your convenience.
peopleSeeking Expert Participation
- Myeloma Specialists
- Oncologists, Hematologists
- Medical researchers
- Advocacy groups